Detailed Mechanism Funding and Narrative

Years of mechanism: 2012 2013 2014 2015 2016 2017 2018 2019 2020

Details for Mechanism ID: 13668
Country/Region: Mozambique
Year: 2016
Main Partner: Ariel Glaser Pediatric AIDS Healthcare Initiative
Main Partner Program: NA
Organizational Type: NGO
Funding Agency: HHS/CDC
Total Funding: $17,161,676 Additional Pipeline Funding: $5,500,000

NOTE: PEPFAR no longer creates activity narratives for each mechanism. In their place, PEPFAR has begun releasing mechanism specific targets that reveal the achievements and programs that are expected of the funding. If available for this mechanism, these targets are presented below.

Mechanism Allocation by Budget Code for Selected Year
Care: Adult Care and Support (HBHC) $1,335,298
Care: TB/HIV (HVTB) $153,633
Care: Pediatric Care and Support (PDCS) $0
Health Systems Strengthening (OHSS) $362,814
Testing: HIV Testing and Counseling (HVCT) $2,125,709
Biomedical Prevention: Prevention of Mother to Child Transmission (MTCT) $1,699,042
Treatment: Adult Treatment (HTXS) $10,492,973
Treatment: Pediatric Treatment (PDTX) $992,207
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
GEND_GBV By PEP service provision (related to sexual violence services provided) 2017 262
GEND_GBV By type of service: Physical and/or Emotional Violence (Other Post-GBV Care) 2017 1,055
GEND_GBV By type of service: Sexual Violence (Post-Rape Care) 2017 359
GEND_GBV Number of people receiving post-GBV care 2017 1,397
HRH_PRE By Graduates: Laboratory professionals 2017 35
HRH_PRE By Graduates: Nurses 2017 65
HRH_PRE Number of new HCW who graduated from a pre-service training institution or program as a result of PEPFAR-supported strengthening efforts, within the reporting period, by select cadre 2017 100
HRH_PRE Sum of Graduates disaggregates 2017 100
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Female 2017 5,876
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Female 2017 86,768
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Male 2017 4,028
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Male 2017 75,575
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Female 2017 51,199
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Female 2017 468,861
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Male 2017 9,770
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Male 2017 118,252
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2017 70,873
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2017 749,406
HTS_TST Service Delivery Point (Community): Index testing 2017 16,075
HTS_TST Service Delivery Point (Facility): Index testing 2017 57,347
HTS_TST Service Delivery Point (Facility): Other PITC 2017 1,178
HTS_TST Service Delivery Point (Facility): Other PITC 2017 16,272
HTS_TST Service Delivery Point (Facility): Outpatient 2017 34,877
HTS_TST Service Delivery Point (Facility): Outpatient 2017 442,724
HTS_TST Service Delivery Point (Facility): Pediatric 2017 102
HTS_TST Service Delivery Point (Facility): Pediatric 2017 10,790
HTS_TST Service Delivery Point (Facility): PMTCT 2017 22,790
HTS_TST Service Delivery Point (Facility): PMTCT 2017 122,560
HTS_TST Service Delivery Point (Facility): TB Clinics 2017 155
HTS_TST Service Delivery Point (Facility): TB Clinics 2017 2,152
HTS_TST Service Delivery Point (Facility): VCT 2017 11,771
HTS_TST Service Delivery Point (Facility): VCT 2017 81,486
HTS_TST Sum of Aggregated Age/Sex <15 2017 9,904
HTS_TST Sum of Aggregated Age/Sex <15 2017 162,343
HTS_TST Sum of Aggregated Age/Sex 15+ 2017 60,969
HTS_TST Sum of Aggregated Age/Sex 15+ 2017 587,113
HTS_TST Sum of Aggregated Age/Sex disaggregates 2017 70,873
HTS_TST Sum of Aggregated Age/Sex disaggregates 2017 749,456
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive <15 Female 2017 71
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive <15 Female 2017 4,005
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive <15 Male 2017 54
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive <15 Male 2017 3,409
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive 15+ Female 2017 1,574
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive 15+ Female 2017 43,611
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive 15+ Male 2017 561
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive 15+ Male 2017 23,028
PMTCT_ART Already on ART at beginning of current pregnancy 2017 325
PMTCT_ART Already on ART at beginning of current pregnancy 2017 6,550
PMTCT_ART New on ART 2017 489
PMTCT_ART New on ART 2017 9,831
PMTCT_ART Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2017 23,004
PMTCT_ART Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2017 130,221
PMTCT_EID By infants who received a virologic test within 2 months of birth 2017 454
PMTCT_EID By infants who received a virologic test within 2 months of birth 2017 10,465
PMTCT_EID By infants who received their first virologic HIV test between 2 and 12 months of age 2017 204
PMTCT_EID By infants who received their first virologic HIV test between 2 and 12 months of age 2017 4,708
PMTCT_EID Number of infants with a positive virological test result within 12 months of birth 2017 16
PMTCT_EID Number of infants with a positive virological test result within 12 months of birth 2017 378
PMTCT_EID Number of infants with a positive virological test result within 2 months of birth 2017 22
PMTCT_EID Number of infants with a positive virological test result within 2 months of birth 2017 523
PMTCT_EID Sum of Infant Age disaggregates 2017 658
PMTCT_EID Sum of Infant Age disaggregates 2017 15,173
PMTCT_STAT By: Known positives at entry 2017 330
PMTCT_STAT By: Known positives at entry 2017 6,619
PMTCT_STAT By: Number of new positives identified 2017 494
PMTCT_STAT By: Number of new positives identified 2017 9,926
PMTCT_STAT Number of new ANC and L&D clients 2017 23,235
PMTCT_STAT Number of new ANC and L&D clients 2017 131,534
PMTCT_STAT Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2017 23,004
PMTCT_STAT Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2017 130,221
PMTCT_STAT Sum of Positives Status disaggregates 2017 824
PMTCT_STAT Sum of Positives Status disaggregates 2017 16,545
TB_ART Aggregated Age/Sex: Female 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 226
TB_ART Aggregated Age/Sex: Female 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 4,821
TB_ART Aggregated Age/Sex: Male 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 121
TB_ART Aggregated Age/Sex: Male 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 2,597
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period 2017 347
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period 2017 7,416
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period 2017 347
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period 2017 7,416
TB_SCREENDX Screen Result: Screened Positive for TB 2017 14,251
TB_SCREENDX Screen Results: Screened Positive for TB 2017 505
TB_SCREENDX Screened for TB by Age/Sex: <15 Female 2017 292
TB_SCREENDX Screened for TB by Age/Sex: <15 Male 2017 292
TB_SCREENDX Screened for TB by Age/Sex: 15+ Female 2017 3,738
TB_SCREENDX Screened for TB by Age/Sex: 15+ Female 2017 106,077
TB_SCREENDX Screened for TB by Age/Sex: 15+ Male 2017 2,012
TB_SCREENDX Screened for TB by Age/Sex: 15+ Male 2017 57,118
TB_SCREENDX Screened for TB by Age/Sex:<15 Female 2017 7,518
TB_SCREENDX Screened for TB by Age/Sex:<15 Male 2017 7,518
TB_SCREENDX The number of PLHIV who were screened for TB symptoms at the last clinical visit at a HIV facility during the reporting period 2017 6,327
TB_SCREENDX The number of PLHIV who were screened for TB symptoms at the last clinical visit at a HIV facility during the reporting period 2017 178,152
TB_STAT Aggregated Age/Sex: Female 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 645
TB_STAT Aggregated Age/Sex: Female 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 7,872
TB_STAT Aggregated Age/Sex: Male 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 349
TB_STAT Aggregated Age/Sex: Male 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 4,233
TB_STAT Number of registered new and relapsed TB cases with documented HIV status, during the reporting period 2017 12,102
TB_STAT Number of registered new and relapsed TB cases with documented HIV status, during the reporting period 2017 993
TB_STAT Total number of registered new and relapsed TB cases, during the reporting period 2017 993
TB_STAT Total number of registered new and relapsed TB cases, during the reporting period 2017 12,102
TX_CURR Age/Sex: <1 2017 50
TX_CURR Age/Sex: <1 2017 662
TX_CURR Aggregated Age/Sex: <15 Female 2017 256
TX_CURR Aggregated Age/Sex: <15 Female 2017 6,615
TX_CURR Aggregated Age/Sex: <15 Male 2017 256
TX_CURR Aggregated Age/Sex: <15 Male 2017 6,615
TX_CURR Aggregated Age/Sex: 15+ Female 2017 2,917
TX_CURR Aggregated Age/Sex: 15+ Female 2017 95,546
TX_CURR Aggregated Age/Sex: 15+ Male 2017 1,569
TX_CURR Aggregated Age/Sex: 15+ Male 2017 51,462
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2017 4,993
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2017 160,167
TX_CURR Sum of Aggregated Age/Sex <15 2017 512
TX_CURR Sum of Aggregated Age/Sex <15 2017 13,230
TX_CURR Sum of Aggregated Age/Sex 15+ 2017 4,486
TX_CURR Sum of Aggregated Age/Sex 15+ 2017 147,008
TX_CURR Sum of Aggregated Age/Sex disaggregates 2017 4,998
TX_CURR Sum of Aggregated Age/Sex disaggregates 2017 160,238
TX_NEW Aggregated Grouping by Age: <1 2017 50
TX_NEW Aggregated Grouping by Age/Sex: <15 Female 2017 101
TX_NEW Aggregated Grouping by Age/Sex: <15 Female 2017 3,393
TX_NEW Aggregated Grouping by Age/Sex: <15 Male 2017 672
TX_NEW Aggregated Grouping by Age/Sex: <15 Male 2017 38,248
TX_NEW Aggregated Grouping by Age/Sex: 15+ Female 2017 101
TX_NEW Aggregated Grouping by Age/Sex: 15+ Female 2017 3,393
TX_NEW Aggregated Grouping by Age/Sex: 15+ Male 2017 364
TX_NEW Aggregated Grouping by Age/Sex: 15+ Male 2017 20,580
TX_NEW By Age/Sex: <1 2017 662
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2017 1,229
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2017 65,546
TX_NEW Sum of Aggregated Age/Sex disaggregates 2017 1,238
TX_NEW Sum of Aggregated Age/Sex disaggregates 2017 65,614
TX_PVLS Number of adult and pediatric ART patients with a viral load result documented in the patient medical record and /or laboratory records in the past 12 months 2017 1,422
TX_PVLS Number of adult and pediatric ART patients with a viral load result documented in the patient medical record and /or laboratory records in the past 12 months 2017 52,256
TX_PVLS Number of adults and pediatric patients on ART with suppressed viral load results (<1,000 copies/ml) documented in the medical records and /or supporting laboratory results within the past 12 months 2017 1,065
TX_PVLS Number of adults and pediatric patients on ART with suppressed viral load results (<1,000 copies/ml) documented in the medical records and /or supporting laboratory results within the past 12 months 2017 39,188
TX_PVLS Numerator Aggregated Age/Sex: <15 Female 2017 102
TX_PVLS Numerator Aggregated Age/Sex: <15 Female 2017 2,918
TX_PVLS Numerator Aggregated Age/Sex: <15 Male 2017 565
TX_PVLS Numerator Aggregated Age/Sex: <15 Male 2017 21,728
TX_PVLS Numerator Aggregated Age/Sex: 15+ Female 2017 102
TX_PVLS Numerator Aggregated Age/Sex: 15+ Female 2017 2,918
TX_PVLS Numerator Aggregated Age/Sex: 15+ Male 2017 303
TX_PVLS Numerator Aggregated Age/Sex: 15+ Male 2017 11,703
TX_PVLS Numerator: Indication: Routine 2017 297
TX_PVLS Numerator: Indication: Routine 2017 5,452
TX_PVLS Numerator: Indication: Targeted 2017 768
TX_PVLS Numerator: Indication: Targeted 2017 33,737
TX_PVLS_den Denominator Aggregated Age/Sex: <15 Female 2017 136
TX_PVLS_den Denominator Aggregated Age/Sex: <15 Female 2017 3,877
TX_PVLS_den Denominator Aggregated Age/Sex: <15 Male 2017 136
TX_PVLS_den Denominator Aggregated Age/Sex: <15 Male 2017 3,877
TX_PVLS_den Denominator Aggregated Age/Sex: 15+ Female 2017 754
TX_PVLS_den Denominator Aggregated Age/Sex: 15+ Female 2017 28,977
TX_PVLS_den Denominator Aggregated Age/Sex: 15+ Male 2017 405
TX_PVLS_den Denominator Aggregated Age/Sex: 15+ Male 2017 15,604
TX_PVLS_den Denominator: Indication: Routine 2017 396
TX_PVLS_den Denominator: Indication: Routine 2017 7,262
TX_PVLS_den Denominator: Indication: Targeted 2017 1,026
TX_PVLS_den Denominator: Indication: Targeted 2017 44,994
TX_RET Aggregated Age/Sex: <15 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 185
TX_RET Aggregated Age/Sex: <15 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 2,751
TX_RET Aggregated Age/Sex: <15 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 660
TX_RET Aggregated Age/Sex: <15 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 35,410
TX_RET Aggregated Age/Sex: 15+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 185
TX_RET Aggregated Age/Sex: 15+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 2,751
TX_RET Aggregated Age/Sex: 15+ Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 357
TX_RET Aggregated Age/Sex: 15+ Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 19,067
TX_RET Number of adults and children who are still alive and on treatment at 12 months after initiating ART 2017 1,378
TX_RET Number of adults and children who are still alive and on treatment at 12 months after initiating ART 2017 59,901
TX_RET Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up 2017 1,968
TX_RET Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up 2017 77,518
TX_RET_den Aggregated Age/Sex: <15 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 263
TX_RET_den Aggregated Age/Sex: <15 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 3,580
TX_RET_den Aggregated Age/Sex: <15 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 941
TX_RET_den Aggregated Age/Sex: <15 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 45,778
TX_RET_den Aggregated Age/Sex: 15+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 263
TX_RET_den Aggregated Age/Sex: 15+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 3,580
TX_RET_den Aggregated Age/Sex: 15+ Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 508
TX_RET_den Aggregated Age/Sex: 15+ Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 24,659
Cross Cutting Budget Categories and Known Amounts Total: $1,627,569
Human Resources for Health $773,720
Gender: Gender Based Violence (GBV) $853,849
Post GBV Care
Implementation
Capacity building
Monitoring and Evaluation